International Immunology, Vol. 11, No. 12, 2035-2042,
December 1999
© 1999 Japanese Society for Immunology
CD4+ T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-
or IL-4
Institute of Medical Microbiology and Immunology, Panum Institute, University of Copenhagen, 3C Blegdamsvej, 2200 Copenhagen, Denmark
Correspondence to: A. Randrup Thomsen
To investigate the mechanism(s) whereby T cells protect against a lethal outcome of systemic infection with vesicular stomatitis virus, mice with targeted defects in genes central to T cell function were tested for resistance to i.v. infection with this virus. Our results show that mice lacking the capacity to secrete both IFN-
and perforin completely resisted disease. Similar results were obtained using IL-4 knockout mice, indicating that neither cell-mediated nor Th2-dependent effector systems were required. In contrast, mice deficient in expression of CD40 ligand were more susceptible than wild-type mice, and residual resistance in these mice was almost completely abrogated by depletion of CD8+ T cells. In keeping with this, mice lacking both MHC class I and class II expression succumbed to the infection, whereas most class II-deficient mice normally survive. Adoptive transfer experiments using B cell- and T cell-deficient recipients revealed that no protection could be obtained in the absence of B cells, whereas treatment with virus-specific immune (IgG) serum controlled viral spreading to the central nervous system (CNS), but did not necessarily accomplish virus elimination. Taken together, these results underscore that B cells are essential in preventing early infection of the CNS, but T cells are required for long-term survival. CD4+ T cells are most efficient in this context and the key function is to provide cognate help to B cells. However, if CD4+ cell function is compromised, CD8+ T cells become critical and may suffice for survival.
Keywords: antibodies, CD4+ T cells, T cell-mediated immunity, viral infection
Transmitting editor: A. McMichael
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Bartholdy, S. O. Kauffmann, J. P. Christensen, and A. R. Thomsen Agonistic Anti-CD40 Antibody Profoundly Suppresses the Immune Response to Infection with Lymphocytic Choriomeningitis Virus J. Immunol., February 1, 2007; 178(3): 1662 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Ciavarra, A. Stephens, S. Nagy, M. Sekellick, and C. Steel Evaluation of Immunological Paradigms in a Virus Model: Are Dendritic Cells Critical for Antiviral Immunity and Viral Clearance? J. Immunol., July 1, 2006; 177(1): 492 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. N. Kristensen, A. N. Madsen, A. R. Thomsen, and J. P. Christensen Cytokine production by virus-specific CD8+ T cells varies with activation state and localization, but not with TCR avidity J. Gen. Virol., June 1, 2004; 85(6): 1703 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Glass and T. E. Lane Functional Expression of Chemokine Receptor CCR5 on CD4+ T Cells during Virus-Induced Central Nervous System Disease J. Virol., December 6, 2002; 77(1): 191 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Christensen, S. O. Andreasen, J. P. Christensen, and A. R. Thomsen CD11b expression as a marker to distinguish between recently activated effector CD8+ T cells and memory cells Int. Immunol., April 1, 2001; 13(4): 593 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kornbluth The emerging role of CD40 ligand in HIV infection J. Leukoc. Biol., September 1, 2000; 68(3): 373 - 382. [Abstract] [Full Text] [PDF]
|
|